Gansu, China

Na Wang

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Lanzhou University. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Na Wang. Retrieved from https://idiyas.com/inventor/na-wang-leeewvkj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Na Wang - Innovator in Fusion Protein Technology

Introduction

Na Wang is a prominent inventor based in Gansu, China. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. His innovative work focuses on enhancing therapeutic methods for central nervous system inflammations.

Latest Patents

Na Wang holds a patent for a fusion protein designed for alpha-melanocyte stimulating hormone. This fusion protein incorporates a protein transduction domain (PTD), human serum albumin (HSA), and alpha-melanocyte stimulating hormone (α-MSH). The patent outlines a method for preparing this fusion protein and its application in inhibiting or treating central nervous system inflammations. He has 1 patent to his name.

Career Highlights

Na Wang is affiliated with Lanzhou University, where he conducts his research and development activities. His work has garnered attention for its potential impact on medical treatments and therapeutic approaches.

Collaborations

Na Wang collaborates with notable colleagues, including Hongyu Li and Meizhu Wang, who contribute to his research endeavors.

Conclusion

Na Wang's innovative work in fusion protein technology represents a significant advancement in the field of biotechnology. His contributions have the potential to improve treatment options for central nervous system conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…